Morphologic leukemia-free state after venetoclax-based therapy in acute myeloid leukemia is associated with high relapse despite preserved short-term survival. Mediterr J Hematol Infect Dis [Internet]. 2026 Apr. 30 [cited 2026 May 1];18(1):e2026048. Available from: https://www.mjhid.org/mjhid/article/view/6359